🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to assess the safety and ability of BioThrax and AV7...
Status
Completed
Location
Johnson County Clin-Trials
Start Date
2018-05-09
Trial ID
NCT03518125
Treatments Being Tested
This study will evaluate the safety and immune response of healthy voluntee...
Status
Completed
Location
Johns Hopkins University Bloomberg School of Public Health
Start Date
2007-01-23
Trial ID
NCT00427167
This pilot phase II trial studies how well giving vaccine therapy works in ...
Status
Completed
Location
University of Southern California
Start Date
2004-05
Trial ID
NCT00085189
RATIONALE: Vaccines made from peptides may help the body build an immune re...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2006-12
Trial ID
NCT00722839
Treatments Being Tested
RATIONALE: Biological therapies, such as agatolimod sodium, may stimulate t...
Status
Completed
Location
University of Iowa/Holden Comprehensive Cancer Center
Start Date
2004-10
Trial ID
NCT00438880
This randomized, phase 2, double-blinded, multicenter study is designed to ...
Status
Active Not Recruiting
Location
Accellacare of Hickory
Start Date
2023-12-05
Trial ID
NCT05997264
This phase 1 clinical trial will evaluate the safety, reactogenicity, and i...
Status
Active Not Recruiting
Location
University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine
Start Date
2025-12-05
Trial ID
NCT07221162
Treatments Being Tested
RATIONALE: Biological therapies, such as agatolimod, may stimulate the immu...
Status
Terminated
Location
The Ohio State University Wexner Medical Center
Start Date
2009-02
Trial ID
NCT00824733
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells ...
Status
Completed
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2002-03
Trial ID
NCT00040950
Treatments Being Tested